ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs
ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs
Authorised
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Product identification
Medicine name:
ReproCyc PRRS EU lyophilisate and solvent for suspension for injection for pigs
ReproCyc PRRS EU Lyofilisaat voor suspensie voor injectie
ReproCyc PRRS EU Lyophilisat pour suspension injectable
ReproCyc PRRS EU Lyophilisat zur Herstellung einer Injektionssuspension
Active substance:
- Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Porcine reproductive and respiratory syndrome virus, type 1, strain PRRS 94881, Live10000000.00/50% tissue culture infectious dose1.00Dose
Pharmaceutical form:
-
Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
-
Intramuscular use
-
Pig
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI09AD03
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Available in:
-
Belgium
Package description:
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 200 ml (100 doses) and Cardboard box of 25 solvent vials of 200 ml (100 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 100 ml (50 doses) and Cardboard box of 25 solvent vials of 100 ml (50 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 25 lyophilisate vials of 20 ml (10 doses) and Cardboard box of 25 solvent vials of 20 ml (10 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 200 ml (100 doses) and Cardboard box of 12 solvent vials of 200 ml (100 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 100 ml (50 doses) and Cardboard box of 12 solvent vials of 100 ml (50 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 12 lyophilisate vials of 20 ml (10 doses) and Cardboard box of 12 solvent vials of 20 ml (10 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 200 ml and 1 solvent vial of 200 ml (100 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 100 ml and 1 solvent vial of 100 ml (50 doses).
- Lyophilisate:Type I amber glass vials with bromobutyl rubber stopper and aluminium seal.Solvent:High density polyethylene (HDPE) vials with a bromo- or chlorobutyl rubber stopper and aluminium seal. Cardboard box of 1 lyophilisate vial of 20 ml and 1 solvent vial of 20 ml (10 doses).
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Vetmedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Vetmedica GmbH
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V474897
Date of authorisation status change:
Reference member state:
-
Ireland
Procedure number:
- IE/V/0444/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Combined File of all Documents
English (PDF)
Download Published on: 30/11/2025